The CAN-AIM team is developing novel methods, using prospective longitudinal cohorts, to study drug safety and effectiveness.

The CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research’ (CAN-AIM) team was funded by the CIHR to develop novel methods, using prospective longitudinal cohorts, to study drug safety and effectiveness.

The team funding is provided through the Drug Safety and Effectiveness Network (DSEN), which has been working jointly with Health Canada, along with stakeholders from across Canada, to respond to key knowledge gaps regarding the safety and effectiveness of drugs used in the real-world.

DSEN has asked CAN-AIM and the other network-funded teams, to respond to queries on drug safety and efficacy, which arise from Health Canada and other regulatory parties.